Category Archives: Corporate

Specialty Medical Providers Envision, AmSurg to Merge

  Envision Healthcare Holdings Inc. (Greenwood Village CO) and AmSurg Corp. (Nashville TN) agreed to merge, in a deal that will create a company providing a range of hospital-related services worth some $10 billion. The… Read more »

First False Claims Act Settlement Turns on Cancer-Drug Survival Data

In the first False Claims Act settlement that turns on cancer-drug survival data, Roche Holding AG’s (Basel CHE) Genentech unit and OSI Pharmaceuticals LLC (Farmingdale NY) agreed to pay $67… Read more »

Glaxo Accelerates Regulatory Plan for Triple Combo Treatment for COPD

GlaxoSmithKline PLC (London) moved to consolidate its lead in a new class of three-in-one inhaled lung drugs on Thursday with plans to file its product for U.S. approval by the… Read more »

Clover Health Inc. Still a Favored to Disrupt the Trillion-Dollar Insurance Market

Clover Health Inc. (San Francisco) raised $160 million from private investors Friday, suggesting the sector is still a favorite among venture capitalists betting such startups can disrupt the trillion-dollar insurance… Read more »

Pfizer Acquires Anacor Pharma for $5.2 Billion

Pfizer Inc. (New York City) is buying Anacor Pharmaceuticals Inc. (Palo Alto CA) in a $5.2 billion deal to add an eczema gel to its portfolio, just a month after… Read more »

Johnson & Johnson Hit with $55 Million Verdict in Talc Powder Trial

Johnson & Johnson (New Brunswick NJ) must pay $55 million to a 62-year-old South Dakota woman who blamed her ovarian cancer on the company’s talcum powder in the second such… Read more »

Pfizer Earnings Exceed Estimates; Company Raises 2016 Forecast

Pfizer Inc. (New York), which last month abandoned its $160 billion quest for Allergan PLC (Dublin IRL), reported quarterly results that blew past analysts’ estimates on sales of its new… Read more »

Pfizer Pays $785 million to Resolve a 14-year-old Lawsuit

Pfizer Inc. (New York City) agreed to pay nearly $785 million to resolve a 14-year-old lawsuit claiming its Wyeth unit overcharged the government by hiding the discounts it was giving… Read more »

AbbVie Agrees to Buy Stemcentrx, Reports Jump in Earnings

U.S. biopharmaceutical firm AbbVie Inc. (North Chicago) on Thursday said it will acquire cancer biotech company Stemcentrx Inc. (South San Francisco) in a roughly $5.8 billion cash and stock deal that would expand… Read more »

Abbott to Acquire St. Jude Medical for $25 Billion

A rash of deals on Thursday showed that healthcare companies are convinced, regardless of tax benefits, that bigger is not only better, it is essential. The more than $40 billion… Read more »